The start-up meeting of Tyroserleutide Phase III clinical trial in the Wuhan Union Hospital was successfully held at Wuhan New Beacon International Hotel on 17 November 2011. Relevant experts of the Wuhan Union Hospital, Clinical Research Coordinator and research assistants totally 12 people attended the conference.
Our Marketing Director introduced the current development of our company and expressed that we will try our best to assist in the smooth running of the whole clinical trial. Our medical department also gave a detailed introduction of the protocol and the operation procedure of Tyroserleutide Phase III clinical trial, and Medpace (the Clinical Research Organization of this clinical trial) also explained Good Clinical Practice rules during the conference. We believe through this conference, the Tyroserleutide Phase Ⅲ clinical trial of this research center will be successfully accomplished with strict standards.